Tanke Biosciences Corporation

Tanke Biosciences Corporation

TNBI
Tanke Biosciences CorporationUS flagOther OTC
0.02
USD
- -
- -
422,498.00Market Cap
2007 Y
2008 Y
2009 Y
2010 Y
2011 Y
2012 Y
TTM
Revenue per Share
- -
- -
- -
1.87
1.82
2.14
1.72
Basic EPS, GAAP
-0.02
-0.05
-0.05
0.25
-0.24
-0.02
-0.12
Free Cash Flow per Basic Share
-0.01
-0.03
-0.03
0.13
0.19
-0.19
-0.47
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.09
-0.14
-0.19
0.54
0.21
0.19
0.12
Tangible Book Value per Share
-0.01
-0.04
-0.08
0.93
1.15
1.1
1.09
Basic Weighted Avg Shares
- -
- -
- -
11
13
13
13
Sales/Revenue/Turnover
- -
- -
- -
20
24
29
23
Operating Margin (%)
- -
- -
- -
21.76
7.3
15.87
-0.25
Depreciation Expense
- -
- -
- -
- -
- -
1
1
Net Income, GAAP
- -
- -
- -
3
-3
- -
-2
Effective Tax Rate (%)
- -
- -
- -
13.62
- -
138
31.63
Profit Margin (%)
- -
- -
- -
13.62
-13.16
-0.74
-7.15
Working Capital
- -
- -
- -
5
15
10
7
LT Debt
- -
- -
- -
- -
5
1
1
Total Equity
- -
- -
- -
10
16
16
16
Return on Invested Capital (%)
- -
- -
- -
61.23
- -
-6.93
- -
Return on Capital (%)
- -
- -
- -
40.09
- -
-7.19
5.61
Return on Common Equity (%)
- -
- -
- -
- -
-73.34
-8.07
-66.71

Capital Structure

FRC

in mil. unless spec.
Mar'13
Jun'13
Sep'13
ST Debt
8
9
9
LT Borrowings
1
1
1
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
13
13
13
Market Capitalization
1
3
3

Working Capital

FRC

in mil. unless spec.
Mar'13
Jun'13
Sep'13
Total Current Assets
22
22
20
Cash, Cash Equivalents & STI
6
5
5
Accounts Receivable, Net
2
2
3
Inventories
1
2
2
Total Current Liabilities
12
13
12
Payables & Accruals
3
3
3
ST Debt
8
9
9
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-6,341.93%
0.43%
Free Cash Flow
- -
-2,109.52%
-204.11%
Net Income, GAAP
- -
-2,573.4%
-93.3%
Sales/Revenue/Turnover
- -
- -
19.84%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2011
6
5
6
7
24
2012
5
7
10
7
29
2013
5
6
6
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2011
-0.17
-0.12
-0.11
- -
-0.24
2012
-0.05
0.02
0.07
- -
-0.02
2013
-0.05
0.01
-0.02
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2011
- -
- -
- -
- -
- -
2012
- -
- -
- -
- -
- -
2013
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Vincent W. Renz Jr.
Full Time Employees
130
Sector
Financial Services
Industry
Shell Companies
Address
East Tower of Hui Hao Building Las Vegas People's Republic of China 510627
IPO Date
May 11, 2012
Business
Tanke Biosciences Corporation Tanke Biosciences Corporation (OTC: TNBI) operates as a diversified investment holding company focused on identifying, partnering with, and investing in emerging growth-stage businesses across strategic verticals including energy monitoring, biotechnology, and animal nutrition. Through its wholly-owned subsidiary Best Energy Monitoring LLC, the company provides real-time energy data monitoring and analysis services utilizing Internet of Things (IoT) devices, big data analytics, and artificial intelligence; these solutions target energy consumption optimization in commercial sectors such as food retail, quick-service restaurants, multi-site operations, education, manufacturing, hotels, and clients including KFC, Shell Oil, and Secret Recipe. Its historical biotechnology operations involve the development and production of non-hazardous, environmentally friendly animal feed additives and premix feeds, primarily through prior affiliations with entities like Guangzhou Tanke Industry Co., Ltd. in China. Tanke Biosciences Corporation, founded in 1989 and headquartered in Las Vegas, Nevada, maintains operational interests extending to international markets including Portugal and China. Recent developments include the March 2023 acquisition by Best Energy Monitoring LLC of energy monitoring assets and operations from Kalimah Unipessoal LDA in Portugal; the February 2025 appointment of Vincent Renz as Chief Executive Officer and Board member to drive operational excellence and scaling investments; and the announcement of a joint venture with BrandCraft Holdings, LLC to pursue growth opportunities in complementary industries.

Company News

APIChat
  • Tanke Biosciences Corp Announces the Appointment of John P. Hopkins Executive Chairman of the Board of Directors